FDA Brief

Company record

COSMO KOREA

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about COSMO KOREA.

Warning letters

  1. COSMO KOREA

    FDA told South Korea's COSMO KOREA that its website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers.

    High risk